J&J Medical Connect
Neuroscience
Neuroscience

Congress Materials – Alzheimer's Association International Conference (AAIC 2026)

 

2026 Alzheimer's Association International Conference| Jul 12-15 | London, UK

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

Consistent Cognitive And Functional Outcomes Across Prespecified Subgroups In The Autonomy Trial Evaluating Posdinemab In Early AD

Colell MGV, Veroff A, Bogert J, Coyle PC, Fedgchin M, Berghmans PJ, Henley D, Xu H, Saad ZS, Elwood F, Simen A,Wong J


View poster

Cortical Microstructure from Diffusion MRI Improves Tau PET Prediction Beyond Plasma pTau217 and Macrostructural Atrophy

Ritobrato Datta, Gerard Ridgway, Mario Torso, Pegah Khosropanah, Gayle Wittenberg, Steven A. Chance, Ziad S. Saad


View poster

Safety And Tolerability Of Posdinemab In Early Alzheimer's Disease: Results From The Phase 2 Autonomy Trial

Berghmans PJ, Fedgchin M, Watkins PB, Snoeys J, Tyler R, Meyer M, Bogert J, De Jonghe S, Jeong A, Li L, Henley D, Greenberg H, Marquez L, Xu H, Simen A, Wong J


View poster

Speech-Based Biomarkers for Assessing Cognitive Status in Preclinical Alzheimer’s Disease: Insights from the REtAIN Study

Kyani A, Parisi F, Kaliukhovich DA, Mallol-Ragolta A, Colell MGV, Demanuele C, Farrell K, Linz N, Tröger J, Herrmann J, Wittenberg G, Simen A, Elwood F, Thornton-Wells T, Steukers L


View poster

Speech-Based Biomarkers for Evaluating Tau PET Status in Preclinical Alzheimer’s Disease: Insights from the REtAIN Study

Parisi F, Kaliukhovich DA, Colell MGV, Demanuele C, Linz N, Tröger J, Herrmann J, Slania S, Saad ZS, Wittenberg G, Simen A, Elwood F, Thornton-Wells T, Steukers L, Kyani A


View poster

Tau PET Results From The Phase 2b Autonomy Trial Evaluating Posdinemab In Early Alzheimer’s Disease

Saad ZS, Slania S, Datta R, Zhang X, Li J, Abdollahi R, Huang X, Bogert J, Fedgchin M, Berghmans PJ, Kolb HC, Henley D, Van der Geyten S, Xu H, Wittenberg G, Simen A, Elwood F, Wong J


View presentation slides

 

Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.

J&J Medical Connect

Connect with us

Connect with us

Would you like to clear and leave your conversation? Message history will be lost.